My bookmarksSign up free
Source

Council Decision of 15 May 2025 appointing four members of the Management Board of the European Medicines Agency

Council Decision of 15 May 2025 appointing four members of the Management Board of the European Medicines Agency

Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The following persons are hereby appointed as members of the Management Board of the European Medicines Agency for a period of three years from 15 June 2025: PATIENTS’ ORGANISATIONS DOCTORS’ ORGANISATIONS VETERINARIANS’ ORGANISATIONS Mr Marko KORENJAK Ms Virginie HIVERT Mr Denis LACOMBE Mr Christophe BUHOT

Article 2

Open ↗

This Decision shall enter into force on the date of its adoption.

Other acts of the same type
Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (Text with EEA relevance)Decision (EU) 2020/28 of the European Parliament and of the Council of 27 November 2019 on the mobilisation of the European Union Solidarity Fund to provide assistance to GreeceDecision (EU) 2020/264 of the European Parliament and of the Council of 27 November 2019 on the mobilisation of the European Union Solidarity Fund to provide for the payment of advances in the general budget of the Union for 2020Decision (EU) 2020/265 of the European Parliament and of the Council of 27 November 2019 on the mobilisation of the Flexibility Instrument to finance immediate budgetary measures to address the ongoing challenges of migration, refugee inflows and security threatsCommission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 (Text with EEA relevance)Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 (Text with EEA relevance)Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 (Text with EEA relevance)Commission Implementing Decision (EU) 2019/2032 of 26 November 2019 establishing measures to prevent the introduction into and the spread within the Union of Fusarium circinatum Nirenberg & O’Donnell (formerly Gibberella circinata) and repealing Decision 2007/433/EC (notified under document C(2019) 8359)Council Decision (CFSP) 2019/1944 of 25 November 2019 amending Decision (CFSP) 2016/1693 concerning restrictive measures against ISIL (Da’esh) and Al-Qaeda and persons, groups, undertakings and entities associated with themCommission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 (Text with EEA relevance)Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 (Text with EEA relevance)Commission Implementing Decision (EU) 2019/1957 of 25 November 2019 on the assessment made pursuant to Regulation (EU) 2018/1139 of the European Parliament and of the Council as regards an exemption from certain substantive requirements laid down in Commission Implementing Regulation (EU) No 923/2012 granted by the United Kingdom (notified under document C(2019) 8345) (Only the English text is authentic) (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next